ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care? ; day:12 ; month:4 ; year:2022 ; pages:1-2
Annals of surgical oncology ; (12.4.2022), 1-2
- Creator
-
Flood, Michael P.
Ramsay, Robert
Michael, Michael
Heriot, Alexander G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-022-11749-0
- URN
-
urn:nbn:de:101:1-2022062721340954713469
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Flood, Michael P.
- Ramsay, Robert
- Michael, Michael
- Heriot, Alexander G.
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Neoadjuvant relatlimab and nivolumab in resectable melanoma
ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Neoadjuvant relatlimab and nivolumab in resectable melanoma
ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer